Logo image of NRC

NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

USA - NASDAQ:NRC - US6373722023 - Common Stock

11.66 USD
0 (0%)
Last: 10/24/2025, 8:00:01 PM
11.66 USD
0 (0%)
After Hours: 10/24/2025, 8:00:01 PM
Fundamental Rating

4

Taking everything into account, NRC scores 4 out of 10 in our fundamental rating. NRC was compared to 101 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NRC had positive earnings in the past year.
In the past year NRC had a positive cash flow from operations.
NRC had positive earnings in each of the past 5 years.
Each year in the past 5 years NRC had a positive operating cash flow.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

NRC has a Return On Assets of 12.68%. This is amongst the best in the industry. NRC outperforms 98.02% of its industry peers.
The Return On Equity of NRC (84.06%) is better than 99.01% of its industry peers.
NRC's Return On Invested Capital of 20.28% is amongst the best of the industry. NRC outperforms 94.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NRC is significantly above the industry average of 9.28%.
The last Return On Invested Capital (20.28%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.68%
ROE 84.06%
ROIC 20.28%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

1.3 Margins

The Profit Margin of NRC (12.78%) is better than 99.01% of its industry peers.
In the last couple of years the Profit Margin of NRC has declined.
Looking at the Operating Margin, with a value of 19.88%, NRC belongs to the top of the industry, outperforming 96.04% of the companies in the same industry.
NRC's Operating Margin has declined in the last couple of years.
NRC's Gross Margin of 60.31% is amongst the best of the industry. NRC outperforms 81.19% of its industry peers.
NRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.88%
PM (TTM) 12.78%
GM 60.31%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, NRC has less shares outstanding
Compared to 5 years ago, NRC has less shares outstanding
NRC has a worse debt/assets ratio than last year.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.73 indicates that NRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
NRC has a Altman-Z score of 2.73. This is comparable to the rest of the industry: NRC outperforms 57.43% of its industry peers.
The Debt to FCF ratio of NRC is 8.73, which is on the high side as it means it would take NRC, 8.73 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.73, NRC perfoms like the industry average, outperforming 54.46% of the companies in the same industry.
NRC has a Debt/Equity ratio of 3.61. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NRC (3.61) is worse than 78.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.61
Debt/FCF 8.73
Altman-Z 2.73
ROIC/WACC2.5
WACC8.12%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.70 indicates that NRC may have some problems paying its short term obligations.
NRC has a Current ratio of 0.70. This is amonst the worse of the industry: NRC underperforms 86.14% of its industry peers.
A Quick Ratio of 0.70 indicates that NRC may have some problems paying its short term obligations.
With a Quick ratio value of 0.70, NRC is not doing good in the industry: 80.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

The earnings per share for NRC have decreased strongly by -36.26% in the last year.
The Earnings Per Share has been decreasing by -3.70% on average over the past years.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -4.08% in the last year.
NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.25% yearly.
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.14, the valuation of NRC can be described as correct.
NRC's Price/Earnings ratio is a bit cheaper when compared to the industry. NRC is cheaper than 79.21% of the companies in the same industry.
NRC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.89.
Industry RankSector Rank
PE 15.14
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

NRC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NRC is cheaper than 72.28% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 29
EV/EBITDA 10.06
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.12%, NRC is a good candidate for dividend investing.
NRC's Dividend Yield is rather good when compared to the industry average which is at 2.42. NRC pays more dividend than 99.01% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, NRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

The dividend of NRC decreases each year by -17.40%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

NRC pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP62.38%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

NATIONAL RESEARCH CORP

NASDAQ:NRC (10/24/2025, 8:00:01 PM)

After market: 11.66 0 (0%)

11.66

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-05 2025-08-05
Earnings (Next)10-27 2025-10-27
Inst Owners51.36%
Inst Owner Change-0.17%
Ins Owners9.51%
Ins Owner Change10.19%
Market Cap268.88M
Revenue(TTM)140.31M
Net Income(TTM)17.93M
Analysts45
Price TargetN/A
Short Float %3.58%
Short Ratio4.67
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-26 2025-09-26 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.14
Fwd PE N/A
P/S 1.92
P/FCF 29
P/OCF 12.62
P/B 12.61
P/tB N/A
EV/EBITDA 10.06
EPS(TTM)0.77
EY6.6%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY3.45%
OCF(TTM)0.92
OCFY7.92%
SpS6.08
BVpS0.92
TBVpS-2.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4
Profitability
Industry RankSector Rank
ROA 12.68%
ROE 84.06%
ROCE 26.45%
ROIC 20.28%
ROICexc 21.34%
ROICexgc 67.64%
OM 19.88%
PM (TTM) 12.78%
GM 60.31%
FCFM 6.61%
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 3.61
Debt/FCF 8.73
Debt/EBITDA 2.25
Cap/Depr 189.66%
Cap/Sales 8.58%
Interest Coverage 9.03
Cash Conversion 62.23%
Profit Quality 51.72%
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 2.73
F-Score5
WACC8.12%
ROIC/WACC2.5
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.67%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.39%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-38.68%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%

NATIONAL RESEARCH CORP / NRC FAQ

What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NRC.


What is the valuation status for NRC stock?

ChartMill assigns a valuation rating of 3 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.


What is the profitability of NRC stock?

NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.


How financially healthy is NATIONAL RESEARCH CORP?

The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.


Is the dividend of NATIONAL RESEARCH CORP sustainable?

The dividend rating of NATIONAL RESEARCH CORP (NRC) is 5 / 10 and the dividend payout ratio is 62.38%.